SIGA logo

SIGA Technologies, Inc.

SIGA
Healthcare|Drug Manufacturers - Specialty & Generic|US
$3.10
+0.13 (+4.38%)
DCF Value
$8.71
Tangible Book / Share
$2.29
Cash / Share
$1.64

About

SIGA Technologies, Inc. is a pharmaceutical company with commercialized products, specializing in the health security and infectious disease sectors across the United States. A core offering is TPOXX, an oral antiviral drug formulated to combat human smallpox, a condition caused by the variola virus. Furthermore, the company has forged a strategic collaboration with Cipla Therapeutics. This partnership aims to ensure ongoing innovation and accessibility of antibacterial treatments, particularly those designed to counter biothreats. Founded in 1995, SIGA Technologies' corporate headquarters are located in New York, New York.

Stock Price

-62.1%(1Y)
1M
-5.5%
3M
+1.6%
6M
-35.4%
YTD
-49.3%
1Y
-52.4%
3Y
-35.7%
5Y
-58.3%

Pipeline Summary

11 total trials
2
Phase 1
2
Phase 2
3
Phase 3
2
Phase 4
Completed: 7No Longer Available: 1Withdrawn: 1Active: 1Terminated: 1

Active Trials (1)

Study to Assess the Safety and Immunogenicity of TPOXX® When Administered Orally for 28 Days With JYNNEOS
NCT04957485Smallpox
Phase 2Active
Enrollment: 100 participants

Key Facts

Market Cap$222.7M
Employees49 (+7% YoY)
CEODiem Nguyen
IPO DateSep 10, 1997
Beta1.02
52-Week Range$2.83 – $7.11
Avg Volume656,874
ExchangeNASDAQ
Websitesiga.com

Ownership

Float57.2%
Shares Outstanding71.8M

Recent Insider Trades

Marshall Joseph W IIIOPTION EX.
Jun 9, 202624,116 shares
Marshall Joseph W IIIDISPOSED
Jun 9, 20267,235 shares @ $4.39
Marshall Joseph W IIIAWARD
Jun 9, 202634,169 shares
Marshall Joseph W IIIOPTION EX.
Jun 9, 202624,116 shares
KEANE JOHN MAWARD
Jun 9, 202634,169 shares

Peers

AQSTAquestive Therapeutics, Inc.
$453.1M
CTMXCytomX Therapeutics, Inc.
$477.2M
DRIODarioHealth Corp.
$23.3M
EBSEmergent BioSolutions Inc.
$310.7M
ESPREsperion Therapeutics, Inc.
$661.1M
OLMAOlema Pharmaceuticals, Inc.
$641.4M
ORGOOrganogenesis Holdings Inc.
$104.6M
RIGLRigel Pharmaceuticals, Inc.
$740.7M
Data last updated: Nov 9, 2026, 04:33 AM